Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03KAQ
|
||||
Former ID |
DNC010088
|
||||
Drug Name |
2-Benzylaminomethyl-3-hydroxymorphinan
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530529] | ||
Structure |
Download2D MOL |
||||
Formula |
C25H32N2O
|
||||
Canonical SMILES |
CN1CCC23CCCCC2C1CC4=CC(=C(C=C34)O)CNCC5=CC=CC=C5
|
||||
InChI |
1S/C25H32N2O/c1-27-12-11-25-10-6-5-9-21(25)23(27)14-19-13-20(24(28)15-22(19)25)17-26-16-18-7-3-2-4-8-18/h2-4,7-8,13,15,21,23,26,28H,5-6,9-12,14,16-17H2,1H3/t21-,23+,25+/m0/s1
|
||||
InChIKey |
BGGKLNVUQJUZIE-QQKQFIJSSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [530529] | |
Mu-type opioid receptor | Target Info | Inhibitor | [530529] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.